Daniel Thomas Oakley serves as Executive at BIOANALYTICAL SYSTEMS INC, where they oversee executive responsibilities. Since joining the company, Daniel Thomas Oakley has executed 11 insider transactions totaling $116.4K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 2, 2019 involved receiving (via award) 8,974 shares valued at $0.
Daniel Thomas Oakley currently holds 57,520 shares of BIOANALYTICAL SYSTEMS INC (BASI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel Thomas Oakley has been a net buyer of BASI stock. They have purchased $116.4K and sold $0 worth of shares.
Daniel Thomas Oakley's most recent insider trade was on Dec 2, 2019, when they sold 8,974 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $3.65 |
| Discretionary |
| Sep 6, 2019 | BASI | $6.7K | Purchase | 2,000 | $3.35 | Discretionary |
| Sep 5, 2019 | BASI | $36.2K | Purchase | 10,500 | $3.45 | Discretionary |
| Aug 29, 2019 | BASI | $13.4K | Purchase | 5,000 | $2.69 | Discretionary |
| Aug 23, 2019 | BASI | $7.2K | Purchase | 2,594 | $2.77 | Discretionary |
| Jun 14, 2019 | BASI | $14.9K | Purchase | 7,500 | $1.99 | Discretionary |
| Mar 15, 2019 | BASI | $2 | Purchase | 1 | $1.90 | Discretionary |
| Mar 6, 2019 | BASI | $17.5K | Purchase | 10,000 | $1.75 | Discretionary |
| Mar 1, 2019 | BASI | $193 | Purchase | 125 | $1.54 | Discretionary |
| Feb 27, 2019 | BASI | $16.6K | Purchase | 10,826 | $1.53 | Discretionary |